17Dec
Related Posts
02Sep
icetana (ASX:ICE) secures Sydney Opera House contract
30 Aug 2023 - icetana Limited (ASX:ICE) Non-Executive Chair Matt Macfarlane discusses his transition from the CEO role, the company's artificial intelligence solution, annual recurring revenue growth, and the recent contract secured with the Sydney Opera House.
Read More
19Nov
Redcape Hotel Group (ASX:RDC) – owner & operator
19 Nov 2019 - Redcape Hotel Group Limited (ASX:RDC) CEO, Dan Brady discusses FY19 results, company strategy and creating pub venues that become the hub of local communities.
Read More
31Mar
Recce Pharmaceuticals (ASX:RCE, FSE:R9Q) developing new classes of synthetic anti-infectives
31 Mar 2021 - Recce Pharmaceuticals Limited (ASX:RCE, FSE:R9Q) CEO and Managing Director James Graham talks about progress with the company's lead anti-infective candidate Recce 327, its expanding portfolio of synthetic anti-infectives targeting viral pathogens and a broad range of bacteria, clinical trial results and priorities for 2021.
Read More
13Sep
Healthia (ASX:HLA) FY19 results & outlook
13 Sep 2019 - Healthia Limited (ASX:HLA) Group CEO & Managing Director, Wesley Coote and Chairman, Dr Glen Richards talk about the company's FY19 results and its model of acquiring podiatry and physiotherapy clinics.
Read More
06Sep
45 years in financial services: A conversation with Bernie Fernandes
06 Sep 2024 - Bernie Fernandes, State Manager (WA & SA) of Sequoia Financial Group (ASX:SEQ), talks with CEO and Managing Director Garry Crole. Bernie shares insights for advisors from his long career.
Read More
20Dec
BluGlass’ defense contract and GaNWorks acquisition, propelling quantum laser innovation in 2024
20 Dec 2023 - Explore the latest developments with BluGlass CEO Jim Haden as he delves into the company's significant defense contract win and the strategic acquisition of GaNWorks. Discover how these milestones drive BluGlass' position at the forefront of quantum laser innovation in 2024, unlocking new potentials in defense, quantum computing, and beyond.
Read More
01Jul
SUDA Pharmaceuticals (ASX:SUD) acquires invariant natural killer T (iNKT) cell therapy platform, June 2021
01 Jul 2021 - SUDA Pharmaceuticals Limited (ASX:SUD) CEO & Managing Director Dr Michael Baker discusses the company's acquisition of the invariant natural killer T (iNKT) cell therapy platform from Imperial College London.
Read More
27Sep
Market update with Shaw and Partners, September 2024
27 Sep 2024 - Martin Crabb, Chief Investment Officer at Shaw and Partners, speaks on the mixed market outlook. He discusses growth, financial conditions, central bank policies and valuations. He advocates for a cautious approach focused on stock picking in the current climate, favouring small caps over large caps.
Read More
12Aug
Centuria Capital Group (ASX:CNI) financial year 2020 results & outlook
12 Aug 2020 - Centuria Capital Group (ASX:CNI) Joint CEO John McBain discusses full year 2020 results, acquisition of Augusta Capital, and guidance for FY21.
Read More
30Nov
Novatti Group (ASX:NOV) partnering with UnionPay, Google Pay & Samsung Pay
27 Nov 2020 - Novatti Group Limited (ASX:NOV) Managing Director & CEO Peter Cook talks about the company's recently announced partnerships with UnionPay, Google Pay and Samsung Pay.
Read More